Position in NAMS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,104,079
+$1,258,390 QoQ
Shares Held
121,100
+36.2% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 198 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. NAMS ranks #66 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in NAMS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,104,079 | 121,100 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,845,689 | 88,900 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,118,612 | 88,900 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,477,124 | 87,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,519,429 | 83,900 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,451,323 | 70,900 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,850,400 | 72,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $582,660 | 35,100 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $674,271 | 35,100 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||